Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Repots shows 9 of 10 leading causes of death unchanged from 2023 to 2024

The leading causes of death in the United States remained similar in 2024 and 2023, according to the Sept. 22 National Vital Statistics Reports, a publication from the National Center for Health Statistics.

Repots shows 9 of 10 leading causes of death unchanged from 2023 to 2024

The National Center for Health Statistics published data in September 2024 indicating that the leading causes of death in the United States remained largely unchanged from the previous year. According to the report, nine of the ten leading causes of death retained their rankings from 2023 to 2024. The top five causes were heart disease, cancer, unintentional injuries, cerebrovascular diseases, and chronic lower respiratory diseases.

These five conditions accounted for 70.9% of all deaths in the country. The 10th leading cause was Alzheimer's disease. Infants also experienced similar patterns, with congenital malformations, low birth weight, and sudden infant death syndrome ranking as the top causes. COVID-19, which had been a significant cause of death in recent years, fell out of the top ten leading causes of death in 2024 and also declined in rank across all racial and ethnic groups.

Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at medicalxpress.com →

More in Health & Medicine

Celltrion Steps Up Global Partnering Push at CPHI 2026

Celltrion is stepping up efforts to broaden its global business portfolio beyond biosimilars, using the upcoming CPHI 2026 exhibition in Milan as a platform to pursue partnerships in novel drug…

  • Celltrion intensifies global partnerships at CPHI 2026 in Milan.
  • The company hosts a 46-pyeong booth with meeting rooms and lounge.
  • Focus areas include novel drug development, contract manufacturing, and supply chain resilience.

More from Tuesday 29 September →